Terms: = Brain cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
65 results:
1. Distinguishing IDH mutation status in gliomas using FTIR-atr spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.
Kino S; Kanamori M; Shimoda Y; Niizuma K; Endo H; Matsuura Y
BMC Cancer; 2024 Feb; 24(1):222. PubMed ID: 38365669
[TBL] [Abstract] [Full Text] [Related]
2. atr inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
Oncotarget; 2024 Jan; 15():1-18. PubMed ID: 38227740
[TBL] [Abstract] [Full Text] [Related]
3. DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
Vanderlinden A; Jones CG; Myers KN; Rominiyi O; Collis SJ
Br J Cancer; 2023 Nov; 129(11):1829-1840. PubMed ID: 37777579
[TBL] [Abstract] [Full Text] [Related]
4. Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis.
Araujo Moura AW; da Silva Rodrigues S; de Oliveira TF; Lobato BM; Pereira Cerize NN; Léo P
J Oncol Pharm Pract; 2023 Oct; 29(7):1736-1747. PubMed ID: 37503551
[TBL] [Abstract] [Full Text] [Related]
5. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/atr Pathway in Androgen-Independent Prostate cancer.
Kim HY; Lee SW; Choi SK; Ashim J; Kim W; Beak SM; Park JK; Han JE; Cho GJ; Ryoo ZY; Jeong J; Lee YH; Jeong H; Yu W; Park S
Am J Chin Med; 2023; 51(5):1309-1333. PubMed ID: 37385965
[TBL] [Abstract] [Full Text] [Related]
6. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
[TBL] [Abstract] [Full Text] [Related]
7. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.
Martin B; Garman T; Laramee M; Wang A; Zhang X; Beck E; Wilson K; Klumpp-Thomas C; McKnight C; Xu X; Hagen N; Holland D; Dahmane N; Thomas CJ; Souweidane M
J Control Release; 2023 May; 357():580-590. PubMed ID: 37054779
[TBL] [Abstract] [Full Text] [Related]
8. ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma.
Xie J; Kuriakose T; Bianski B; Twarog N; Savage E; Xu K; Zhu X; He C; Hansen B; Wang H; High A; Li Y; Rehg JE; Tillman HS; Freeman BB; Rankovic Z; Onar-Thomas A; Fan Y; Wu G; Peng J; Miller S; Baker SJ; Shelat AA; Tinkle CL
Neuro Oncol; 2023 Oct; 25(10):1828-1841. PubMed ID: 36971093
[TBL] [Abstract] [Full Text] [Related]
9. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
[TBL] [Abstract] [Full Text] [Related]
10. Critical Appraisal of Paediatric Embryonal cancers Treated with Image-guided Intensity-modulated Proton Therapy.
Sharma DS; Padanthaiyil NM; Krishnan G; Arjunan M; Reddy AK; Mahammood S; Gayen S; Thiyagarajan R; Gaikwad U; Sudarsan RT; Chilukuri S; Jalali R
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):227-236. PubMed ID: 36609026
[TBL] [Abstract] [Full Text] [Related]
11. Sarcoma brain metastases: Tertiary cancer center experience.
Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
[TBL] [Abstract] [Full Text] [Related]
12. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast cancer to Radiotherapy.
Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
[TBL] [Abstract] [Full Text] [Related]
13. Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for treatment of cancer.
Ahmed A; Aziz M; Ejaz SA; Channar PA; Saeed A; Zargar S; Wani TA; Hamad A; Abbas Q; Raza H; Kim SJ
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421710
[TBL] [Abstract] [Full Text] [Related]
14. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract] [Full Text] [Related]
15. Correlation of Clinicopathological Factors with brain Tumor-Related Epilepsy in Glioma.
Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
[TBL] [Abstract] [Full Text] [Related]
16. Predictive Factors for Bilateral Disease in Papillary Microcarcinoma: A Retrospective Cohort Study.
Lindner K; Iwen KA; Kußmann J; Fendrich V
Curr Oncol; 2022 Aug; 29(9):6010-6017. PubMed ID: 36135042
[TBL] [Abstract] [Full Text] [Related]
17. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
[TBL] [Abstract] [Full Text] [Related]
18. Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia.
Pinarbasi-Degirmenci N; Sur-Erdem I; Akcay V; Bolukbasi Y; Selek U; Solaroglu I; Bagci-Onder T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806055
[TBL] [Abstract] [Full Text] [Related]
19. Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis.
Tomic B; Smoljo T; Lalic H; Dembitz V; Batinic J; Batinic D; Bedalov A; Visnjic D
Sci Rep; 2022 Jul; 12(1):11344. PubMed ID: 35790845
[TBL] [Abstract] [Full Text] [Related]
20. cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.
Alim I; Loke J; Yam S; Templeton AS; Newcomb P; Lindor NM; Pai RK; Jenkins MA; Buchanan DD; Gallinger S; Klugman S; Ostrer H
Genet Med; 2022 Sep; 24(9):1821-1830. PubMed ID: 35616648
[TBL] [Abstract] [Full Text] [Related]
[Next]
